Topics

Articles

Healthcare research firm calls out the alarmist predictions over PCSK9s and other new drugs

Where are those missing billions in new-product pharma sales?

Advent joins Thomas Lee Partners in ownership of the clinical, commercial outsourcer

Private-capital injection into inVentiv Health reshuffles life sciences outsourcing

The scale of the cardiovascular market pushes payers to demand quality outcomes data

Cardiovascular therapy: More new drugs for a growing patient base

Bloomberg BusinessWeek rakes over charitable copay programs

Patient copays: the growth mechanism of the pharma industry?

Contract sales cuts for AstraZeneca as Crestor goes off-patent

Company pursues ‘bench to bedside’ commercialization services

Dohmen appoints Joe Nolan to president, Dohmen Life Science Services

Site opens up a Facebook-like “Pages” to vendors and medical organizations

Sermo reaches 30 countries to connect physicians in an online community

Managed care organizations are adjusting rapidly to onslaught of specialty products

2016 EMD Serono Specialty Digest: health plans’ ongoing cost struggle

A raft of new therapies is generating renewed optimism for cancer care, but even as lower-cost biosimilars enter the market, cost is a crippling factor

Oncology: a new era in therapies; same cost concerns

Policymakers look at alternative payment models in oncology

Commercial Channels